| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10428190802535114 |
| P698 | PubMed publication ID | 19160125 |
| P50 | author | Carlo Maria Croce | Q640381 |
| George A. Calin | Q64785850 | ||
| Muller Fabbri | Q66414308 | ||
| P2860 | cites work | miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 |
| Megakaryocyte biology and related disorders | Q24536140 | ||
| Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 | ||
| Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| MicroRNA fingerprints during human megakaryocytopoiesis | Q24546361 | ||
| Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
| MicroRNA genes are transcribed by RNA polymerase II | Q24562649 | ||
| Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters | Q24645192 | ||
| miRiad roles for the miR-17-92 cluster in development and disease | Q24646970 | ||
| MiR-15a and miR-16-1 cluster functions in human leukemia | Q24647555 | ||
| Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma | Q24648226 | ||
| Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder | Q24649158 | ||
| Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model | Q24649526 | ||
| Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes | Q24651802 | ||
| Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin | Q24652323 | ||
| MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation | Q45345507 | ||
| Micro RNAs in animal development | Q52023709 | ||
| MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia | Q24655915 | ||
| Requirement of bic/microRNA-155 for normal immune function | Q24656120 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma | Q24672476 | ||
| Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice | Q24675006 | ||
| CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control | Q24676449 | ||
| Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma | Q24676965 | ||
| MicroRNA-155 is induced during the macrophage inflammatory response | Q24683841 | ||
| MicroRNA profiling of the murine hematopoietic system | Q24811302 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation | Q28139447 | ||
| High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma | Q28236173 | ||
| Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis | Q28256626 | ||
| Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma | Q28260227 | ||
| A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 | ||
| Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181 | Q28279673 | ||
| Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression | Q28283082 | ||
| Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells | Q28287105 | ||
| miR-181a is an intrinsic modulator of T cell sensitivity and selection | Q28294631 | ||
| Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia | Q28306681 | ||
| Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 | Q28510667 | ||
| Regulation of the germinal center response by microRNA-155 | Q29547777 | ||
| The colorectal microRNAome | Q29616082 | ||
| miRNAs, cancer, and stem cell division | Q29618925 | ||
| An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues | Q29619171 | ||
| A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis | Q29619201 | ||
| Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice | Q29619279 | ||
| microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells | Q29619307 | ||
| MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb | Q29619411 | ||
| Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock | Q29619768 | ||
| BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas | Q29622911 | ||
| Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA | Q34099092 | ||
| MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation | Q34212635 | ||
| Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia | Q34313643 | ||
| Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. | Q34460936 | ||
| An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. | Q34625798 | ||
| miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia | Q34700780 | ||
| Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis | Q34708478 | ||
| Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. | Q34712578 | ||
| Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view | Q34760577 | ||
| Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. | Q34768042 | ||
| MicroRNA expression in cytogenetically normal acute myeloid leukemia | Q34775265 | ||
| MicroRNAs in normal and malignant hematopoiesis | Q34785149 | ||
| A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis | Q34787845 | ||
| B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia | Q34830865 | ||
| Dynamic regulation of miRNA expression in ordered stages of cellular development. | Q35677284 | ||
| miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely | Q35758613 | ||
| MicroRNAs: a developing story | Q36083275 | ||
| Mechanisms of B-cell lymphoma pathogenesis | Q36085626 | ||
| MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia | Q36288982 | ||
| Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia | Q36350493 | ||
| A GATA-1-regulated microRNA locus essential for erythropoiesis | Q36491071 | ||
| MAPK signalling: ERK5 versus ERK1/2. | Q36553050 | ||
| MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas | Q36734930 | ||
| MicroRNA-143 and -145 in colon cancer | Q36822477 | ||
| Regulatory mechanisms of microRNAs involvement in cancer | Q36897389 | ||
| MicroRNAs and cell cycle regulation | Q36929340 | ||
| microRNAs and cancer: an overview | Q37249283 | ||
| MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. | Q38305314 | ||
| Microarray-based, high-throughput gene expression profiling of microRNAs | Q38443466 | ||
| Differentiation-linked leukemogenesis in lymphocytes | Q39746908 | ||
| MicroRNA expression profiling in classic Hodgkin lymphoma | Q40033467 | ||
| Downregulation of microRNAs-143 and -145 in B-cell malignancies | Q40076849 | ||
| MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma | Q40135314 | ||
| Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. | Q40195148 | ||
| A high-throughput method to monitor the expression of microRNA precursors | Q40585425 | ||
| Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. | Q41109594 | ||
| Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs | Q41843084 | ||
| Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage | Q42808536 | ||
| P433 | issue | 2 | |
| P921 | main subject | leukemia | Q29496 |
| microRNA | Q310899 | ||
| P304 | page(s) | 160-170 | |
| P577 | publication date | 2009-02-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | MicroRNAs in the ontogeny of leukemias and lymphomas | |
| P478 | volume | 50 |
| Q37259187 | A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas |
| Q33692555 | Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. |
| Q36143915 | Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation |
| Q38251994 | Challenges and opportunities of microRNAs in lymphomas. |
| Q37916411 | Deregulated microRNAs in multiple myeloma |
| Q28397621 | Environmental chemical exposures and human epigenetics |
| Q37084568 | Environmental chemicals and microRNAs |
| Q37691486 | Epigenetic mechanisms regulating normal and malignant haematopoiesis: new therapeutic targets for clinical medicine. |
| Q46608275 | Epigenetic role of miRNAs in normal and leukemic hematopoiesis |
| Q38219046 | Epigenetically regulated microRNAs and their prospect in cancer diagnosis |
| Q34391404 | Epigenetics across the human lifespan |
| Q37583650 | Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation |
| Q36007765 | Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival. |
| Q34450467 | Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a |
| Q34868346 | Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas |
| Q24610579 | HOXA9 regulates miR-155 in hematopoietic cells |
| Q33842759 | High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. |
| Q27316043 | MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia |
| Q35975009 | MicroRNA Expression Analysis in Patients with Primary Myelofibrosis, Polycythemia vera and Essential Thrombocythemia. |
| Q49788568 | MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis |
| Q39373900 | MicroRNA-297b-5p/3p target Mllt3/Af9 to suppress lymphoma cell proliferation, migration and invasionin vitroand tumor growth in nude mice |
| Q38088117 | MicroRNAs Involved in Anti-Tumour Immunity |
| Q90238190 | MicroRNAs and their involvement in T-ALL: A brief overview |
| Q24618980 | MicroRNAs in mouse models of lymphoid malignancies |
| Q35711092 | MicroRNAs: New Players in Multiple Myeloma |
| Q34605730 | Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology |
| Q46707173 | Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia |
| Q84597682 | Pathobiology of the microRNA system |
| Q37868870 | Role of microRNAs in lymphoid biology and disease |
| Q38904484 | Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage. |
| Q28645911 | The role of micro-ribonucleic acids in normal hematopoiesis and leukemic T-lymphogenesis |
| Q45411856 | Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas |
| Q39491088 | miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid |
| Q36525161 | miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 |
| Q24644535 | miRGen 2.0: a database of microRNA genomic information and regulation |
| Q36946773 | microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia |
| Q50544689 | microRNAs: Key Players in Hematopoiesis |
Search more.